C12Y 203/01012
Dihydrolipoyllysine-residue acetyltransferase
Official title: Dihydrolipoyllysine-residue acetyltransferase (2.3.1.12)
C12Y203/01012 (Dihydrolipoyllysine-residue acetyltransferase) appears on 9 US grants and 14 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 14
- Assignees
- 12
- Inventors
- 51
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 2 |
| 2016 | 2 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex E1-α, E1-β, and E2 subunits for the treatment of maple syrup urine disease2 Jun 2026US 12,644,102 B2ModernaTX, Inc.
- Synthetic biochemistry molecular purge valve module that maintain co-factor balance30 Dec 2025US RE50,715 E1The Regents of the Univesity of California
- Bioconversion of short-chain hydrocarbons to fuels and chemicals27 Feb 2024US 11,913,049 B2
- Enzymatic methods for butanol production4 Jul 2023US 11,692,207 B2Newpek S.A. De C.V.
- Synthetic biochemistry molecular purge valve module that maintain co-factor balance3 Nov 2020US 10,822,623 B2The Regents of the University of California
- Microorganism with enhanced pyruvate dehydrogenase complex dihydrolipoyllysine-residue acetyltransferase activity and method for producing l-amino acids using same17 Sep 2026US 2026/0275364 A1Cj Cheiljedang Corporation
- Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals19 Sep 2024US 2024/0309417 A1
- Genetically modified microorganism for producing 3-hydroxyadipic acid and/or alpha-hydromuconic acid, and method for producing chemical product7 Dec 2023US 2023/0392112 A1Toray Industries, Inc.
- Production of pyruvate or products derived from pyruvate using modified escherichia coli24 Nov 2022US 2022/0372451 A1
- Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease4 Aug 2022US 2022/0243182 A1ModernaTX, Inc.
Most cited
By later US patents